Company intelligence / Profile preview
Valbiotis
Périgny, Nouvelle-Aquitaine, FRAinvestisseurs.valbiotis.com ↗
- Ownership
- Private
- Employees
- ~44
- Development stage
- Other
01
Overview
French biotech developing plant-derived formulations targeting metabolic diseases through multi-target mechanisms with four clinical-stage candidates and strategic pharma partnerships.
- Therapeutic areas
- GastroenterologyEndocrinologyCardiovascular
- Modalities
- Plant-based active substances(Presumed) small molecules/natural compounds
- Industry
- Biotech
02
Drug pipeline
7 assets6 more assets in the full pipeline.
03
Partnerships
Nestlé Health Science[3]University of La Rochelle[2]CNRS[2]Clermont Auvergne University[2]
Beyond the preview
Go deeper on Valbiotis.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Valbiotis.